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At first sight, the nervous and vascular systems seem to share little in common. However, neural and vascular
cells not only are anatomically closely tied to each other, but they also utilize and respond to similar classes of
signals to establish correct connectivity andwiring of their networks. Recent studies further provide evidence
that this neurovascular crosstalk is more important for understanding the molecular basis of neurological
disease than originally anticipated. Moreover, neurovascular strategies offer novel therapeutic opportunities
for neurodegenerative disorders.Introduction
Accounting for only 2% of the body mass, yet receiving 20% of
the cardiac output, the mammalian brain critically relies on an
elaborate vascular network for its oxygen and nutrient supply.
Estimations suggest that the human brain contains up to 100
billion vessels, i.e., a vessel for each neuron. The vascular
system developed more recently in evolution than the nervous
system. In primitive organisms such as C. elegans, the need
for motor coordination triggered development of a nervous
system, but since oxygen diffuses to all cells in these small
species, there was no need to develop an elaborate vasculature.
Only later in evolution, when organisms became larger and
(metabolically) more active, a more efficient system for oxygen
transportation was required. Hence, in vertebrates, a highly
branched vasculature lined by an endothelium developed to
nourish organs including the central nervous system (CNS) and
peripheral nervous system (PNS).
A key ancestral function of vessels is to supply oxygen
and nutrients. Hence, shortage of oxygen is a key stimulus to
vascularize the developing CNS. However, the role of vessels
in the CNS extends beyond merely supplying nutrients. Indeed,
by releasing ‘‘angiocrine’’ factors, endothelial cells (ECs) not
only produce instructive signals for neural development, but
also support normal functioning, ensure maintenance, and
promote reparative regeneration of the CNS (Butler et al.,
2010). Moreover, to maintain neuronal homeostasis, brain
vessels have a blood-brain barrier (BBB), comprising ECs,
pericytes (e.g., mural cells of the vascular smooth muscle
lineage surrounding capillaries), astrocytic endfeet, and neurons
(Zlokovic, 2008). This ‘‘neurovascular unit’’ is only one of the
examples of the intertwined connection between the neural
and vascular system.
Elucidating the crosstalk between both systems is important,
not only to better understand the molecular and cellular basis
of how the nervous system operates, but also to develop novel
therapeutic strategies for neurological disorders. In this review,
we will discuss key principles andmolecules governing develop-
ment and function of the CNS vasculature, focusing on recent
discoveries with a translational potential, rather than providing406 Neuron 71, August 11, 2011 ª2011 Elsevier Inc.an encyclopedic survey. For reasons of brevity, we will discuss
the neurovascular link in the PNS only briefly.
Vessel Development in the CNS
Model of Vessel Branching
Initial vascularization of the embryonic CNS relies on ‘‘vasculo-
genesis,’’ when angioblasts from the paraxial mesoderm
coalesce to form a primitive network around the neural tube in
the so-called perineural vascular plexus (PNVP). Via inward
sprouting, new vessel branches invade the neural tube, a pro-
cess termed ‘‘angiogenesis,’’ to establish the intraparenchymal
vascular network.
Vascular development is a complex process, orchestrated by
an interplay of numerous molecules (Carmeliet and Jain, 2011a).
Several of them regulate angiogenesis in multiple organs and
thus act as ‘‘general’’ angiogenic factors, but emerging evidence
indicates that organs establish their own vascular bed in a
specific pattern, adapted to meet local metabolic and functional
needs. Here, we will limit our discussion to some of the key
general angiogenic agents, implicated in a recently postulated
vessel branching model (Carmeliet and Jain, 2011a), and
thereafter discuss a few examples of brain-specific angiogenic
factors.
Vessel branching relies on a coordinated collective migration
of ECs, in which one particular cell, the ‘‘tip cell,’’ takes the
lead to guide the following ‘‘stalk cells’’ that elongate the sprout
(Carmeliet and Jain, 2011a). This tip cell is exposed to the highest
levels of VEGF, released by hypoxic neural tissue (Figure 1A).
Signaling by the VEGF receptor VEGFR2 instructs this tip cell
to extend numerous filopodia that explore the environment and
guide the branch toward the source of proangiogenic factors.
VEGF signaling in the tip cell induces expression of Dll4, which
activates the Notch1 receptor on neighboring ECs to prevent
tip cell induction and thereby induce a stalk cell identity (Fig-
ure 1B). Stalk cells proliferate, elongate the stalk, and form
a lumen. Once new vessel branches fuse and become perfused,
ECs resume quiescence and form a monolayer of ‘‘phalanx
cells’’ with a streamlined surface to conduct flow; these cells
have oxygen sensors to readjust endothelial morphogenesis to
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Figure 1. General and CNS-Specific Angiogenic Mechanisms
(A) Scheme illustrating vessel sprouting from the perineural vascular plexus into the neuro-epithelium. Radial glia secrete factors to facilitate guidance and growth
of the angiogenic sprout.
(B) Signaling events that regulate guidance of the tip cell (green) and proliferation of the stalk cells (purple). VEGF signaling in the tip cell induces upregulation of
Dll4, which activates Notch signaling in neighboring stalk cells. Wnts induce b-catenin-mediated transcription of target genes to stimulate stalk cell proliferation
and brain EC differentiation. The GPR124 orphan receptor also regulates vessel formation in the CNS.
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angiogenic pathways have been implicated in tip cell guidance
and outgrowth, stalk cell elongation, and phalanx cell stabiliza-
tion, even though their precise role in brain vascularization has
not always been characterized (Carmeliet and Jain, 2011a).
Selective Mechanisms of Brain Vascularization
Some angiogenic pathways play a more important role in the
vascularization of the developing CNS than of peripheral organs.
Periventricular vessel growth in the telencephalon progresses
in a ventral-to-dorsal gradient, established by compartment-
specific homeobox transcription factors in ECs (Dlx1/2, Nkx2.1,
and Pax6) (Vasudevan et al., 2008). Though it is unclear how
these factors regulate EC responses, these findings challenge
the dogma that vessels sprout only in response to angiogenic
signals, locally produced by hypoxic brain cells.
Another pathway implicated in the formation of theCNSvascu-
lature is Wnt/b-catenin signaling (Daneman et al., 2009; Liebner
et al., 2008; Stenman et al., 2008). The neuroepithelium secretes
Wnt ligands that bind to the Frizzled (Fzd)/Lrp5/6 receptor
complex on ECs, leading to stabilization of b-catenin and tran-
scription of downstream targets (Figure 1B). Combined loss of
Wnt7a and Wnt7b impairs vascular integrity and invasion in the
neuroectoderm (Dejana, 2010). Wnt promotes BBB differentia-
tion of brain ECs, stimulates proliferation of stalk cells, and pro-
motes stability of new vascular connections (Phng et al., 2009).
The WNT cascade intertwines with other angiogenic pathwaysincluding VEGFR2 and Notch1 signaling, which enhance b-cate-
nin’s activity (Phng et al., 2009); Wnt signaling also upregulates
Notch1 in a feedback loop (Figure 1B). In line with findings that
mutations in the human Fzd4 receptor or Lrp5 coreceptor cause
retinal hypovascularization, endothelial loss of Fzd4 in mice
causes vascular defects and disrupts the BBB (Ye et al., 2009).
Only a few molecules have been implicated in brain-specific
vascular development. The orphan G protein-coupled receptor
GPR124 regulates vessel sprouting from the PNVP in the fore-
brain (Anderson et al., 2011; Cullen et al., 2011; Kuhnert et al.,
2010). Signaling via receptor Cxcr4 in response to ligand
Cxcl12b controls the formation of arteriovenous connections in
the CNS but not in the trunk of zebrafish embryos (Bussmann
et al., 2011; Fujita et al., 2011). During basilar artery formation,
venous-derived ECs expressing Cxcr4 are attracted by Cxcl12b,
produced by the hindbrain adjacent to the basilar artery. Once
this vascular connection is established, hemodynamics downre-
gulate Cxcr4 to silence tip cell behavior and sprouting.
It is noteworthy that signals like Wnt and Cxcl12b (SDF-1a in
mice) are not unique for developmental CNS vascularization
(they can also signal vessel growth in pathology), but at least
during particular developmental windows, they seem to be
more selectively involved in CNS vascular development. Other
molecules must control brain vascularization—identifying these
organ-specific candidates may offer opportunities for selectively
targeting brain vessels in brain disease.Neuron 71, August 11, 2011 ª2011 Elsevier Inc. 407
Figure 2. Maturation of the Angiogenic Sprout and Mural Cell Recruitment
The endothelial tip cell secretes PDGF-B to recruit PDGFRb+ pericytes to the growing sprout. Pericytes, in turn, secrete Ang1 to activate endothelial Tie2
receptors, thereby increasing interendothelial junctions and endothelial quiescence; its role in pericyte coverage has been recently challenged.
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Once a luminized vessel is formed, maturation of the vessel wall
is necessary to ensure a stable network and optimal blood flow.
The tightly aligned EC barrier gains stability via coverage of
mural cells, i.e., pericytes around capillaries and smooth muscle
cells (SMCs) around arterioles that deposit extracellular matrix
(ECM) and affect EC functions.
In the vertebrate forebrain, ECs derive from cephalic meso-
derm, while mural cells arise from ectodermal tissue, i.e., the
neural crest and neuroectoderm (Etchevers et al., 2001; Kurz,
2009). By contrast, pericytes in the posterior brain originate
from mesodermal cells, though they can also derive from the
bone marrow, at least in the adult. The sharp demarcation of
vascular regions inmural cell coverage likely occurred at a critical
switch in evolution, when the neural crest contributed to cephalic
structures (forebrain, jaws) that offered vertebrates the advan-
tage of higher order coordination and active feeding lifestyle.
The role of mural cells extends beyond providing mechanical
stability alone, as ECs and mural cells influence each other’s
proliferation, differentiation, and survival (Carmeliet and Jain,
2011a). Noteworthy, the segmental appearance of some cere-
bral vascular malformations (for instance, Sturge-Weber
syndrome) has been linked to the metameric origin of neural
crest cells and their defined migration patterns into distinct brain
regions (Krings et al., 2007).
Compared to peripheral vessels, cerebral vessels exhibit
a number of distinct features. In no other organ, capillary endo-
thelial cells are thinner yet have a tighter barrier, a higher degree
of pericyte coverage, and a more intricate communication with
the surrounding parenchymal cells. However, the cerebral
arteries show a thinner, more fragile wall (thinner adventitia,
underdeveloped external elastic lamina) and arborize in a highly408 Neuron 71, August 11, 2011 ª2011 Elsevier Inc.branched and bifurcated network, conditions that render them
vulnerable to aneurysms and atherosclerosis caused by shear
stress (Nixon et al., 2010). Moreover, region-specific differences
determine vulnerability to vascular disease. For instance,
compared to the gray matter, the microvascular density is lower
in the subcortical white matter and its arteries are coiled as they
lack a tight parenchymal support. This, together with the fact that
terminal arterioles in this region exhibit limited potential for collat-
eral flow, renders the white matter especially vulnerable to
ischemia and hemorrhages due to small vessel disease.
Vessel Maturation: Recruitment of Pericytes
Pericytes are stellate-shaped cells that ensheath large areas of
capillary ECs in an umbrella-like fashion, make peg-socked
contacts with ECs, and lie embedded in the EC basement
membrane. To recruit pericytes around vessels, ECs secrete
PDGF-B binding PDGFRb on pericytes (Gaengel et al., 2009)
(Figure 2). Furthermore, Notch3 signaling promotes maturation
of pericytes, likely in response to the EC-derived Jagged-1 (Liu
et al., 2010). In turn, pericytes secrete angiopoietin-1 (Ang1)
that binds to the endothelial Tie2 receptor to promoteECsurvival,
cell-cell adhesion, and pericyte coverage (Augustin et al., 2009).
A recent study challenged the dogma that Ang1 is necessary for
pericyte recruitment and coverage of quiescent vessels. They
showed that Ang1 acts as a ‘‘brake’’ to balance the enhanced
angiogenic activity in development or pathology and is necessary
to form properly sized and branched vessels (Jeansson et al.,
2011). Finally, mural cell-derived TGFb1 can promote pericyte
differentiation and maturation, though this signaling pathway
can also stimulate vessel growth in a context-dependent
pattern (Pardali et al., 2010). Additional signals regulate pericyte
recruitment and maturation, EC survival and quiescence, and
basement membrane deposition (Carmeliet and Jain, 2011a).
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Mice with mutations in the PDGF-B/PDGFRb pathway form
vessels with varying levels of pericyte recruitment; analysis of
these lines reveals that pericytes have context-dependent
effects on CNS vessel morphogenesis in growing versus quies-
cent vessels. Embryos carrying PDGFRb mutations form
cerebral endothelial-lined channels but recruit fewer pericytes,
with the most severely affected vessels becoming enlarged,
microaneurysmatic and leaky (Gaengel et al., 2009). Complete
embryonic absence of pericytes results in perinatal death due
to edema and hemorrhage from vessels displaying EC hyper-
plasia and overactivation, indicating that pericytes function
to silence EC growth in growing vessels (Gaengel et al., 2009).
Pericyte deficiency can also contribute to (pathological) neoves-
sel growth, not only by unleashing the brake to EC proliferation
but also by creating a proangiogenic environment. In adult dia-
betic retinopathy for instance, pericyte degeneration renders
vessels leaky and causes bleeding, which evokes hypoxia,
a strong stimulus of angiogenesis.
Moremodest pericyte deficiency in quiescent vessels in adult-
hood decreases vessel density (Bell et al., 2010), likely because
insufficient production of pericyte-derived EC survival factors
such as Ang1 and VEGF favors vessel pruning (Quaegebeur
et al., 2010). Another explanation is that pericytes control angio-
genic sprouting, though the relevance of this process requires
further study. In the CNS, pericytes are detected around
PDGF-B expressing tip cells, where they affect vascular branch-
ing (Liu et al., 2009). Some studies documented so-called ‘‘peri-
cyte-driven’’ angiogenesis, where pericyte sleeves attract ECs
via expression of VEGF and the proteoglycan NG2.
Sealing Off the Neurovascular Unit viaMatrix Anchorage
The different cellular components of the vascular wall must be
tightly sealed to each other and anchored to the perivascular
matrix. This requires deposition of a basement membrane, inter-
actions with matrix components, and establishment of cell-cell
junctions (Carmeliet and Jain, 2011a). For instance, by linking
the endothelial cytoskeleton to the ECM, the superfamily of in-
tegrin surface receptors affects EC proliferation, migration and
morphogenesis (Desgrosellier and Cheresh, 2010). Hence, defi-
ciency of av-integrin causes cerebral bleeding, while loss of
SMC integrin b1 results in hemorrhages due to weak EC-pericyte
interactions (Abraham et al., 2008).
Development of the Blood-Brain Barrier
CNS vessels establish a BBB to secure neuronal homeostasis
and seal off the neural environment from circulating substances
and cells. This physical barrier consists of a specialized endothe-
lium that is sealed by tight and adherens junctions to restrict
paracellular permeability (Zlokovic, 2008). Specialized trans-
porters such as the glucose transporter GLUT1 and the trans-
ferrin receptor CD71 control uptake of nutrients across the
barrier, while pump and receptor mechanisms dispose of toxic
and waste products, such as the P-glycoprotein drug efflux
transporter and the scavenging receptor low-density lipoprotein
receptor-related protein-1 (LRP-1). The endothelium is sup-
ported by a basement membrane and enwrapped by pericytes,
astrocytic endfeet, and neuronal synapses, all together estab-
lishing the neurovascular unit.Role of Astrocytes in BBB Formation
The barrier properties of theCNS endothelium are not genetically
preprogrammed and isolated brain ECs in culture lose their BBB
characteristics, raising the question of which neighboring cell
type accounts for the induction of the barrier characteristics
(Rocha and Adams, 2009). Pericytes establish direct contact
with ECs, while astrocytes lie abluminally, though their endfeet
can make direct contact with ECs (Figure 3). Historically, astro-
cytes received most attention and were shown to induce BBB
properties in non-CNS-derived endothelium in vivo. Coculture
experiments support a role for astrocytes in restricting BBB
permeability by secreting Ang1, TGFb, GDNF, and FGF2. By
expressing SSeCK, a protein C kinase substrate with antiangio-
genic activity, astrocytes induce BBB maturation via an Ang1-
mediated increase in EC tight junctions.
Perivascular astrocytic foot processes are characterized by
polarized distribution of intramembranous orthogonal arrays of
particles (OAPs) (Wolburg et al., 2011). These complexes contain
the water channel aquaporin 4 (AQP4), the potassium channel
Kir4.1, and a dystroglycan-dystrophin complex. OAP clustering
relies on interactions with ECM proteins in the glial limiting
membrane separating pericytes and astrocytes. AQP4 and
Kir4.1 play a role in ion and water homeostasis at the glial-endo-
thelial interface. The significance of OAPs remains, however,
poorly understood. Some reports suggest an influence on BBB
permeability, while others refute such effect (Wolburg et al.,
2011).
Role of Pericytes in BBB Formation
Pericytes seem to have more important roles in the establish-
ment of the BBB than previously anticipated, in part because
the BBB is formed in the embryo when pericytes are present
but astrocytes have not arisen yet (Daneman et al., 2010)
(Figure 3). The development of astrocytes at later time points
raises the question of whether these cells might control BBB
function more importantly after birth. Using different hypomorph
PDGFRb mutants with variable levels of residual pericyte
coverage, pericytes were found to play a critical role in establish-
ing a barrier function in vivo, with the microvascular permeability
inversely correlating with pericyte coverage (Daneman et al.,
2010). Pericyte losswas associatedwith junctional abnormalities
and increased transendothelial transport, without overt changes
in BBB markers. Levels of Ang1, a pericyte-derived mediator of
endothelial quiescence promoting the formation of interendothe-
lial junctions, were decreased in pericyte-deficient mice (Dane-
man et al., 2010), while expression of angiopoietin-2 (Ang2), an
Ang1 antagonist, was enhanced.
Role of Neural Progenitors in BBB Formation
Neural progenitors also participate in establishing the BBB by
secreting Wnt ligands that activate b-catenin signaling in ECs
(Figure 3). Genetic studies show that b-catenin signaling in ECs
in vivo is required to induce and maintain BBB properties such
as the expression of the glucose transporter Glut1 and the tight
junction molecule claudin3 (Daneman et al., 2009; Liebner et al.,
2008; Stenman et al., 2008). Moreover, avb8 integrin-mediated
adhesion of neural progenitors and their glial progeny to the
neurovascular unit are required for morphogenesis of the fore-
brain vasculature. Indeed, deletion of avb8 in neural progenitors
results in the formation of misshaped EC clusters and cerebralNeuron 71, August 11, 2011 ª2011 Elsevier Inc. 409
Figure 3. Establishment of the BBB
Wnts secreted from neural progenitors during vascular brain development induce BBB characteristics in endothelial cells (ocher). Pericytes, recruited by
PDGF-B/PDGFRb, strengthen endothelial barrier properties and induce attachment and polarization of astrocytes upon perinatal generation and recruitment to
the BBB. Astrocytes function to maintain BBB properties postnatally.
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cyte coverage (McCarty, 2009).
Role of the Neurovascular Link in Development
More than five centuries ago, the Belgian anatomist Vesalius
discovered that nerves and vessels track along each other to
reach their target. The vascular and nervous system display
intriguing parallelisms in their stereotyped architectural pattern-
ing and functional organization (Carmeliet and Tessier-Lavigne,
2005). Explanations for this copatterning are that neurons and
ECs respond to the same (classes of) molecular cues, or that
they coregulate each other’s migration. As the vascular system
developed later in evolution than the nervous system, vessels
are believed to have co-opted some of the genetic pathways
for similar biological processes. Four classical axon guidance
cue families (netrins, slits, ephrins, semaphorins) guide growth
cones of axons and regulate navigation of endothelial tip cells
via similar principles of repulsion and attraction, which we will
illustrate here only with a few (recent) prototypic examples.
Endothelial Cell Guidance by Neuronal Signals
Endothelial tip cells extend filopodia that explore their surround-
ings for guidance cues. Neuropilin-1 (Nrp1) was discovered as
a receptor for semaphorins in repulsive axon guidance but is
also a coreceptor for VEGF and other angiogenic factors on
ECs (Carmeliet and Tessier-Lavigne, 2005). Nrp1 null embryos410 Neuron 71, August 11, 2011 ª2011 Elsevier Inc.succumb due to cardiovascular malformations because of an
interrupted interaction with VEGF (Fantin et al., 2009; Rosenstein
et al., 2010). Nrp1 blockade is currently being evaluated as novel
anti-angiogenic strategy for the treatment of cancer (Bagri et al.,
2009). Semaphorins, other ligands of Nrp1, usually inhibit angio-
genesis, though some can also be stimulatory (Capparuccia and
Tamagnone, 2009). By activating Plexin-D1 directly, semaphorin
3E (Sema3E) controls vessel navigation via distinct mechanisms.
In intersomitic vessels in zebrafish embryos, Sema3E, produced
by perivascular cells, prevents ECs from erroneous navigation in
unwanted territories, presumably by reorienting the cytoskeleton
of the tip cell itself. By contrast, in postnatal mouse retinal vascu-
larization, Sema3E produced by perivascular neurons activates
Plexin-D1 on tip cells to coordinate vessel navigation by fine-
tuning the precise balance of tip versus stalk cells, required for
even growing vessel fronts and branching (Fukushima et al.,
2011; Kim et al., 2011). Molecularly, Sema3E/Plexin-D1 fine-
tunes VEGF’s activity in a negative feedback by suppressing
Dll4 expression in tip cells.
Netrins can act as chemoattractants when activating the DCC
and DSCAM receptor families, and as repellants when binding
to the Unc5 receptor family (Unc5a-d). Consistent with a role
of Netrin in vessel guidance, aberrant filopodia formation on tip
cells and enhanced vessel branching were observed after dele-
tion of Unc5b, while Netrin-1 overexpression inhibited vessel
Neuron
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inhibits EC growth via binding to neogenin and Unc5b (Lejmi
et al., 2008). However, others reported divergent effects of Netrin
family members (Chan et al., 2010). These seemingly contradic-
tory reports may be possibly reconciled by findings that the
angiogenic activity of Netrin-1 results from blocking apoptosis
induced by its unbound Unc5b dependence receptor (Castets
and Mehlen, 2010), but will require further study.
Slit glycoproteins act as repulsive axon guidance cues by
activation of the Roundabout receptor family (Robo1-3) (Ypsi-
lanti et al., 2010). The endothelial-specific Robo4 promotes
vascular integrity by suppressing VEGFR2 signaling (London
et al., 2009), but the responsible ligand of Robo4 remains
debated since neither an interaction with Slit nor a vascular
phenotype for Slit or Robo members has been demonstrated.
Instead, Robo4 reduces VEGF responses via binding to Unc5b
in ECs (Koch et al., 2011).
Binding of ephrin ligands to Eph receptors induces bidirec-
tional signal transduction in both the receptor cell (‘‘forward
signaling’’) and ligand cell (‘‘reverse signaling’’) (Pitulescu and
Adams, 2010). Both events allow sorting and positioning of cells,
determined by their expression of particular Ephs and ephrins. In
the CNS, Eph-ephrin signaling mostly generates repulsive
signals for navigating axons (Klein, 2009). ECs use Eph-ephrin
signaling to regulate their guidance and maturation. For in-
stance, during coalescence of a primitive vascular plexus, repul-
sion of ephrin-B2+ arterial and EphB4+ venous ECs prevents
intermingling and ensures segregation into separate venous
and arterial territories (Swift and Weinstein, 2009). Repulsive
Eph-ephrin interactions also control the segregation of EphB4+
venous-fated ECs from ephrin-B2+ arterial-fated ECs in a
common precursor vessel to establish the dorsal aorta and
cardinal vein in zebrafish embryos (Herbert et al., 2009). More-
over, ephrin-B2 reverse signaling regulates vessel guidance by
controlling VEGFR internalization and tip cell behavior. ECs ex-
pressing a mutant ephrin-B2 are unable to internalize VEGFR2
and VEGFR3, thereby impairing VEGF signaling and filopodia
formation (Sawamiphak et al., 2010; Wang et al., 2010b).
Neuron/Axon Guidance by Vascular Signals
The neurovascular link is bidirectional and molecules originally
discovered as angiogenic molecules also have roles in establish-
ing the connectivity of the nervous system—they have been
termed ‘‘angioneurins’’ (Zacchigna et al., 2008). One of the
best-known examples is VEGF, which regulates neuronal cell
migration (Ruiz de Almodovar et al., 2009), axon guidance
(Erskine et al., 2011; Ruiz de Almodovar et al., 2011), turning of
leading processes of migrating cerebellar neurons (Ruiz de
Almodovar et al., 2010), and dendritogenesis (Licht et al.,
2010). VEGF-D, another member of the VEGF family, controls
the length and complexity of dendrites in hippocampal neurons
and regulates memory formation (Mauceri et al., 2011). More-
over, D. melanogaster and C. elegans lacking an elaborate
vascular network express an ancestral VEGF variant that affects
nervous development (Zacchigna et al., 2008). Sema3E stimu-
lates axon elongation via binding to a Plexin-D1/Nrp1 complex
with subsequent VEGFR2 activation (Bellon et al., 2010). Other
‘‘angioneurins’’ include members of the TGFb1, Shh, Wnts,
BMPs, FGFs, and other families (Zacchigna et al., 2008).An intriguing question is whether hypoxia, a proangiogenic
stimulus, regulates CNS wiring. Initial support heretofore is
provided by genetic studies in C. elegans. When challenged by
low oxygen, this invertebrate mounts a protective organismal
survival response by upregulating the Eph-receptor VAB-1,
a repulsive guidance receptor in the CNS; the price to pay for
the protection is that axon pathfinding is perturbed (Pocock
and Hobert, 2008). Hypoxia also activates circuits for processing
sensory information, underscoring that oxygen levels influence
CNS wiring (Pocock and Hobert, 2010).
Neurovascular Congruency
Another example of the neurovascular link is the coalignment of
vessels and nerves, with nerves guiding vessels tracking along-
side nerves, and vice versa. For instance, neural crest cells
(NCCs) give rise to autonomic nerves that innervate SMCs of
peripheral resistance arteries (Ruhrberg and Schwarz, 2010).
These autonomic nerves regulate contractility and tissue perfu-
sion. Resistance arteries attract their own innervation by
secreting guidance cues for sympathetic neurons including
VEGF, artemin, NT-3, and endothelin-3 (Ruiz de Almodovar
et al., 2009). Besides its role in establishing the autonomic inner-
vation, VEGF remains necessary for the maintenance of this
autonomic nervous network in adulthood. Reduced production
of VEGF by SMCs in VEGF-hypomorph VEGFv/v mice renders
periarterial autonomic nerves dysfunctional (Storkebaum et al.,
2010). Pial arteries also possess (para)sympathetic and sensory-
motor perivascular nerves that originate from peripheral ganglia,
referred to as ‘‘extrinsic’’ innervation, but little is known about
the molecules regulating the development and maintenance of
these nerves. In the other direction, axons guide vessels to
cotrack along them. For instance, certain embryonic arteries
are associated with sensory nerves and follow axonal patterning,
though the precise molecular nature of these vascular guidance
signals remains to be determined (Zacchigna et al., 2008).
Endothelial and Neural Cell Fate Decisions
Some signals commonly determine cell fate decisions in the
nervous and vascular system. For instance, VEGF and Notch
regulate neurogenic commitment of neural stem cells (NSCs)
(Pierfelice et al., 2011) as well as endothelial arterial/venous
cell fate specification (Swift and Weinstein, 2009). Genetic
studies in zebrafish show that VEGF upregulates Notch expres-
sion to drive arterial EC differentiation during development. In the
PNS, VEGF produced by Schwann cells determines arterial
specification of ECs in cotracking vessels (Ruiz de Almodovar
et al., 2009). Notch determines arterial development, as illus-
trated by the loss of arterial identity of SMCs resulting in
a venous-like appearance of cerebral arteries (thinner media,
dilated lumen) upon SMC-selective disruption of Notch (Gridley,
2010). In these mice, the anterior communicating arteries in the
circle of Willis fail to anastomose, impairing collateral blood
flow and rendering them vulnerable to cerebral artery occlusion.
The Neurovascular Niche
While neural cells stimulate vessel growth by releasing VEGF and
other angiogenic factors, vessels also crosstalk to neural cells,
not only by functioning as conduits for oxygen and nutrient
supply, but also by releasing angiocrine signals to promote neu-
ronal development (Butler et al., 2010). This seems to be partic-
ularly the case in the neurogenic niche, where periventricularNeuron 71, August 11, 2011 ª2011 Elsevier Inc. 411
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Figure 4. Multiple Interactions of Neurogenic Progenitors with Blood Vessels
(A and B) In the ventricular zone of the developing cortex (A) and in the adult SEZ (B), cells with stem cell properties—radial glia and adult NSCs, respectively—
divide at a distance from the blood vessels. In contrast, their more differentiated progeny—basal progenitors in development (A) and transit amplifying
progenitors (TAPs) in the adult (B)—are attracted by and migrate to the blood vessels of the periventricular vascular plexus to divide in the perivascular niche.
During development, these divisions generate mainly cortical neurons that leave the vascular niche to migrate to the cortex (A); similarly, TAPs in the adult SEZ
give rise to neuroblasts that migrate to the olfactory bulb (B).
(C) Neuroblasts use blood vessels as a cellular substrate for this migration. Blood vessels guide p75-expressing neuroblasts by releasing BDNF, while neuro-
blasts regulate the local BDNF concentration by releasing GABA to induce BDNF uptake via TrkB by local astrocytes.
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genesis (Vasudevan et al., 2008). Consistent with reports that
hypoxia promotes stemness (Mohyeldin et al., 2010), NSCs412 Neuron 71, August 11, 2011 ª2011 Elsevier Inc.reside in a hypoxic neurogenic niche in the ventricular zone at
a distance from the vascular supply (Mazumdar et al., 2010) (Fig-
ure 4A). Basal progenitors, already committed to the neuronal
Neuron
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plexus in the adjacent subventricular zone (Johansson et al.,
2010). Intriguingly, vessels invade the subventricular germinal
zone when the first basal progenitors arise (Vasudevan et al.,
2008). These progenitors become aligned with vessels and
undergo neurogenic divisions in close vicinity of vessel branch
points. In contrast, divisions that generate NSCs or basal
progenitors to expand the pool of stem and progenitor cells
take place in the less vascularized part of the ventricular zone
(Johansson et al., 2010). These spatial and temporal patterns
suggest a role for vessels in the neurogenic niche to coordinate
neurogenesis, but how oxygen and/or vessel-derived signals
fine-tune this process and which angiocrine molecular signals
are involved requires further study. In line, cultured ECs release
signals that stimulate proliferation of neural precursors and
bias their differentiation to a neuronal fate (Shen et al., 2004).
Role of the Neurovascular Crosstalk in Disease
Throughout adulthood, communication between the nervous
and vascular system remains required for maintenance of the
BBB, for providing endothelial-derived neurotrophic functions
and promoting neuroregeneration. Defects in this crosstalk can
result in neurological disorders.
Dysregulation of Cerebral Vascular Perfusion
While vessels feed neural cells with nutrients and oxygen, neural
cells provide feedback to vessels regarding their metabolic
needs. The regulation of brain perfusion takes place at various
levels: large arteries receive innervation from central autonomic
nerves, while SMCs in smaller arterioles respond to signals
from astrocytes and possibly neurons, allowing regional dy-
namic adjustments of blood flow in response to changing
neuronal activity (functional hyperemia) (Attwell et al., 2010).
Pericytes can alter the capillary diameter but whether they
contribute to functional hyperemia remains debated (Attwell
et al., 2010). Findings that the vasoreactivity of CNS vessels
with subnormal coverage of pericytes is perturbed suggest at
first sight that pericytes regulate functional hyperemia (Bell
et al., 2010), but possible SMC defects were not excluded
and a recent study refutes a role for pericytes in physiological
conditions (Ferna´ndez-Klett et al., 2010). Overall, the precise
role of pericytes in cerebral blood flow (CBF) regulation requires
further study.
Deficient CBF control occurs in various neurological diseases
and can contribute to neuronal damage via neurovascular un-
coupling and hypoperfusion (Iadecola, 2004). Oxidative stress
in ECs seems to be a common cause of perturbed functional
hyperemia and cerebrovascular autoregulation in Alzheimer’s
disease (AD), arterial hypertension, and diabetes mellitus by
interfering with endothelial production of vasodilatory
substances. In AD for instance, amyloid-b (Ab) triggers endothe-
lial production of oxygen radicals by the NADPHoxidase via acti-
vation of the Ab receptor CD36 (Iadecola, 2010; Park et al.,
2011). Besides NADPH oxidase as a major source of oxygen
radical formation, mitochondria in ECs can also contribute.
Indeed, mitochondria are more abundant in ECs of the brain
than of other peripheral organs and may also generate oxidative
stress. For instance, in MELAS, a mitochondrial disease charac-
terized by encephalomyopathy, EC oxidative damage due todysfunctional mitochondria compromises vasodilatation, explain-
ing the predisposition for stroke-like episodes (Koga et al., 2006).
Vascular mural cell abnormalities can also contribute to perfu-
sion deficits. For instance, in AD, SMCs upregulate the transcrip-
tion factors SRF and myocardin (MyoCD) that increase arterial
contractility and thus could reduce CBF (Chow et al., 2007).
Cerebral autosomal-dominant arteriopathy with subcortical
infarcts and leucoencephalopathy (CADASIL) is another exam-
ple of cerebrovascular dysregulation long believed to be due to
abnormal SMC structure and function (Joutel, 2011). CADASIL
is an inheritable small vessel disease caused by mutations in
Notch3 and characterized by progressive subcortical ischemic
injury. Both in CADASIL patients and mouse models, disturbed
functional hyperemia and cerebrovascular autoregulation occur
as one of the earliest events, suggesting a disease-initiating
role. However, contrary to common belief in the past that
CADASIL is a SMC-centric disease only, impaired CBF auto-
regulation in combination with capillary rarefication rather than
SMC degeneration and vascular sclerosis seem to be of primary
causal importance (Joutel, 2011).
In pathological conditions, pericyte dysfunction or deficiency
can impair cerebrovascular reactivity. After stroke, local CBF is
decreased for protracted periods, even after reperfusion of the
occluded vessel; pericyte contraction in response to reactive
oxygen species (ROS) has been involved in this no-reflow
phenomenon (Yemisci et al., 2009), though other mechanisms
also contribute. It is therefore tempting to speculate that these
mural cells might have a more important role in pathological
than physiological conditions.
Breakdown of the BBB
BBB breakdown has been recognized in various neurological
diseases (Zlokovic, 2008). In stroke, meningitis, and trauma,
BBB leakiness is a consequence of the insult, but evidence indi-
cates that primary BBB dysfunction can also cause neurologic
diseases via several mechanisms: leakage of neurotoxic
proteins (immunoglobulins, thrombin, fibrin) resulting in ROS
production and inflammation, accumulation of waste products
(Ab) due to defective disposal, deficient nutrient transport, insuf-
ficient production of neurotrophic factors, entry of inflammatory
cells leading to immune responses and possibly axonal demye-
lination, and perivascular edema compromising perfusion.
At the molecular level, dysregulated PDGFRb signaling is one
of the few pathways, discovered so far to cause functional BBB
maintenance defects evoking secondary neurological dysfunc-
tion. Indeed, disruption of this EC/pericyte molecular commu-
nication causes progressive pericyte loss and coincident BBB
hyperpermeability after birth (Armulik et al., 2010; Bell et al.,
2010). However, as these mutant lines lack pericytes already in
development, it is unclear to what extent loss of pericytes in
adulthood can contribute to BBB leakage; inducible gene
inactivation studies in pericytes will be required to answer this
question. Structural junctional abnormalities, increased transen-
dothelial transport and basal lamina deficits, thought to impair
anchoring of astrocytic endfeet to the vessel wall, are believed
to cause the BBB dysfunction in pericyte-deficient mice (Armulik
et al., 2010; Bell et al., 2010). The (pre)clinical importance of BBB
defects is reflected by findings that these mice, displaying an
age-dependent reduction in CBF and BBB breakdown, developNeuron 71, August 11, 2011 ª2011 Elsevier Inc. 413
Figure 5. Vascular Defects in Mouse Models of Vascular Neurodegeneration
(A) Healthy vessels (left panel) maintain normal blood flow and possess a functional BBB to enable sufficient supply of oxygen and nutrients to the surrounding
brain parenchyma, while protecting it from harmful substances in the blood.
(B) Reduced expression levels of an angiogenic factor (VEGF) or transcription factor (Meox2) in adult VEGFv/v and Meox2+/ mice cause EC dysfunction and,
eventually, degeneration, leading to hypoperfusion, which can contribute to neuronal injury and possibly also neurodegeneration.
(C) Pericyte dysfunction or loss in adult PDGFRb+/ mice causes BBB disruption with secondary capillary rarefication, overall resulting in BBB breakdown and
hypoperfusion that cause an adult-onset neurodegenerative-like phenotype in these mice.
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loss along with cognitive deficits (Bell et al., 2010) (Figure 5).
These insights illustrate that pathological BBB leakiness not
only is the result of neuronal insults but can also initiate neurode-
generation, arguing for a causative role of vascular deficits in
neurodegeneration.
There is also initial evidence for possible causative role of
a dysfunctional BBB in other neurodegenerative diseases. For
instance, in an amyotrophic lateral sclerosis (ALS) mousemodel,
leakiness of the blood-spinal cord barrier owing to reduced
expression of tight junctions and Glut1 precedes the onset
of motoneuron degeneration (Garbuzova-Davis et al., 2011).
However, deletion of mutant SOD in ECs in an ALSmousemodel
overexpressing mutant SOD attenuates BBB leakiness without
improving survival (Zhong et al., 2009) (Figure 6). The relevance
of BBB abnormalities in ALS thus requires further elucidation.
AD represents the prototypic example of a dysfunctional
neurovascular unit. The main culprits are Ab peptides, formed
after cleavage of amyloid precursor protein (APP) by BACE
(b-site AAP-cleaving enzyme) and subsequently g-secretase.
While mutations of these candidate genes result in increased
Ab production in rare familial cases, the more common late-
onset sporadic form is caused by impaired Ab clearance
(Mawuenyega et al., 2010). Besides clearance via microglia
and macrophages, Ab is also transported across the BBB by
LRP-1 or passively drained along perivascular spaces (Bell and414 Neuron 71, August 11, 2011 ª2011 Elsevier Inc.Zlokovic, 2009)—both mechanisms are impaired in AD. As a
result of atherosclerotic or small vessel disease (conditions
associated with AD), the vessel wall is stiffened, and pulsatile
flow and perivascular fluid movement are reduced, impeding
Ab drainage. Ab clearance is further compromised due to the
vasoconstriction by hypercontractile SMCs and to the reduced
endothelial LRP-1 expression, both resulting from overexpres-
sion of MyoCD and SRF (Bell et al., 2009; Chow et al., 2007).
Since short-term administration of Ab1-40 but not of the plaque-
forming Ab1-42 is known to induce oxidative damage of cerebral
vessels and impair CBF (Iadecola, 2010), the resultant elevated
Ab levels will in turn cause vascular dysfunction (Figure 7).
Eventually, Ab accumulation in the vascular wall, a condition
referred to as cerebral amyloid angiopathy (CAA), destroys
microvascular structure and function, leading to loss of the
BBB integrity along with an inflammatory response, compro-
mising neuronal viability. Since exposure of cultured neuronal
cell lines to hypoxia or of mice to severe ambient hypoxia is
capable of upregulating the expression of APP cleaving enzymes
and transcription factorsMyoCD and SRF, vascular insufficiency
might further enhance amyloid production and compromise
amyloid clearance, causing a vicious circle whereby Ab accumu-
lation aggravates vascular deficits and vice versa. However,
whether sufficient hypoxia is present in early AD to upregulate
these factors requires further study. The cerebral amyloid
accumulation in mouse models of arterial hypertension and
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Figure 6. Vascular Phenotype in ALS
VEGF levels are reduced in ALS patients and rodent
models leading to endothelial dysfunction, hypoperfusion,
and BBB breakdown including loss of endothelial tight
junctions and the GLUT1 transporter that is responsible
for glucose transport across the BBB. Despite the fact
that VEGF administration delays the disease in rodents,
it is currently not known whether and how vascular
dysfunction contributes ALS.
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ReviewCADASIL provide additional evidence for a causal role of
vascular defects in AD pathology and illustrates how AD and
cerebrovascular disease share common risk factors.
Hypoperfusion Due to Insufficient Angiogenic Signaling
Cerebral hypoperfusion resulting in neurological symptoms can
be caused by inadequate patency of supply vessels, as occurs
in cerebral angiopathies of large supply arteries when affected
by atherosclerosis or in small vessel disease in the context of
hypertension, diabetes mellitus, or CADASIL (Moskowitz et al.,
2010). Brain hypoperfusion due to vascular abnormalities can
also occur in neurodegenerative disorders such as AD, ALS,
and Parkinson’s disease (PD) (Zlokovic, 2008). However, the
causative nature of these vascular alterations has been debated
in the past: do vascular defects cause neurodegeneration
and/or accelerate disease progression, or are they a conse-
quence of neuronal loss and cerebral hypometabolism.
At least some studies have been instrumental in revealing
a causal link. First, VEGFv/vmice with reduced VEGF levels suffer
adult-onset motoneuron degeneration, reminiscent of ALS
(Oosthuyse et al., 2001; Ruiz de Almodovar et al., 2009). The
CNS of VEGFv/v mice is hypoperfused, likely due to a lack of
EC survival signaling (Lee et al., 2007). It remains, however, unre-
solved whether and how hypoperfusion occurs prior to neuronal
loss, and what precisely the relative role is of hypoperfusion
versus reduced VEGF-mediated neuroprotection (Figure 6).
Second, a reduction in brain perfusion and vessel density in
PDGFRb mutant mice or in mice lacking Meox2 (Mesenchyme
Homeobox 2, a transcription factor regulating vascular differ-
entiation) results in neuronal loss and cognitive impairment
(Bell et al., 2010) (Figure 5). Also noteworthy, vascular dysfunc-
tion is present early in neurodegenerative diseases, even priorNeto onset of neuronal death (Garbuzova-Davis
et al., 2011; Iadecola, 2010), implying that
vascular abnormalities actively contribute to
neurodegeneration.
Whether hypoperfusion in neurodegenera-
tion is due to insufficient angiogenic signaling
and if so, which molecules are at play remains
largely outstanding. In AD, besides perturbing
ECs structurally and functionally by causing
oxidative stress, Ab squelches VEGF, inhibits
VEGF binding to its receptor, suppresses EC
mitogenic and survival responses to VEGF
and FGF2, and induces EC autophagy, senes-
cence, and apoptosis (Donnini et al., 2010;
Patel et al., 2010). AD patients have reduced
levels of endothelial progenitor cells, impli-
cated in repairing damaged endothelial lining.Subnormal VEGF levels in AD patients might aggravate
vascular insufficiency, but elevated VEGF levels have been
also documented, presumably in an effort to compensate for
impaired VEGFR2 signaling (Ruiz de Almodovar et al., 2009).
Not only ECs are targeted in AD, since Ab deposits have
been also detected around degenerating pericytes and
SMCs, but to what extent dysfunctional mural cells causally
contribute to AD’s pathogenesis remains outstanding. Overall,
despite upregulation of angiogenic molecules, angiogenesis is
nonproductive in AD and cannot repair the damaged CNS
vasculature.
Human genetic studies provide only limited support for a link
between angiogenic factors and AD so far (Ruiz de Almodovar
et al., 2009). In ALS, VEGF gene haplotypes that lower VEGF
levels are associated with an increased risk in genetically homo-
geneous populations, while a meta-analysis of over 7,000 indi-
viduals documented an increased risk of ‘‘at-risk’’ VEGF gene
variations in males (Lambrechts et al., 2009). VEGF levels in
the cerebrospinal fluid of ALS patients are decreased, which
could relate to impaired VEGF mRNA translation due to mutant
SOD1. ALS can also result frommutations in angiogenin, another
putative angiogenic factor (Li and Hu, 2010).
Cerebrovascular Malformations
In the healthy adult, cerebral vessels are quiescent and con-
stitute a guardian for the CNS microenvironment. However,
abnormal molecular regulation of vessel quiescence can lead
to abnormal vessel growth, all or not accompanied with leaki-
ness. In many cases, these lesions occur sporadically and their
underlying molecular basis remains elusive. We will therefore
highlight two prototypic monogenic hereditary cerebrovascular
diseases characterized by vascular malformations for whichuron 71, August 11, 2011 ª2011 Elsevier Inc. 415
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Figure 7. Hypothethical Model of the Role of Blood
Vessel Dysfunction in AD
(A) Atherosclerosis in large arteries (top left), Ab-induced
vasoconstriction of smaller arterioles (top middle), and EC
abnormalities in capillaries (top right) can impair perfusion
and cause hypoxia.
(B) Downregulation of LRP-1 and vasoconstriction in
response to upregulation of SRF and MyoCD can reduce
Ab clearance, while induction of the cleaving enzyme
BACE can increase Ab production. Whether hypoxia in
early AD is sufficiently severe to cause these changes
remains outstanding (indicated by question marks). If so,
hypoxia could provide a link between the vascular defects
and Ab accumulation to create a self-reinforcing vicious
cycle between Ab aggregation, hypoperfusion, and
hypoxia.
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more complete overview of the known monogenic cerebrovas-
cular anomalies.
Human hereditary teleangiectasia (HHT), also known as
Rendu-Osler-Weber disease, is an autosomal-dominant in-
herited vascular dysplasia causing arteriovenous malformations
(AVMs) and teleangiectasias in the brain and other organs (Shov-
lin, 2010). Typical for AVMs are the presence of arteriovenous
shunts without intervening capillary bed, and the presence of
dilated tortuous veins that, despite perfusion at arterial pressure,
fail to become ‘‘arterialized’’ but maintain walls with venous
molecular signature and appearance. Like CCMs (see below),
they can cause neurological symptoms of varying severity and
expressivity including headache, focal neurological deficits,
seizures, and hemorrhagic stroke. Autosomal dominant muta-
tions have been identified in three genes—i.e., ENG encoding
endoglin, ACVRL1 encoding activin receptor-like kinase 1
(ALK1), and SMAD4 encoding SMAD4, all functioning in TGFb
signaling (Pardali et al., 2010). The TGFb pathway controls vessel416 Neuron 71, August 11, 2011 ª2011 Elsevier Inc.wall stability and balances the angiogenic
response during vascular remodeling.
How haploinsufficient TGFb signaling gives
rise to vascular malformations is incompletely
understood, though reduced mural cell
coverage together with increased EC growth
may cause vessel dilatation without accompa-
nying maturation, resulting in deregulated
vessel remodeling and formation of fast-flow
arteriovenous shunts (Shovlin, 2010). A second
hit, i.e., injury, induction of vessel growth,
inflammation or hemodynamic overload, or
other stimuli, is likely required to initiate focally
a deregulated angiogenic response leading to
AVM formation. TGFb intersects with Notch
signaling in establishing mature cerebrovas-
cular circuits, since an interaction between
SMAD4 and RBP-J, a downstream target of
Notch, is necessary for endothelial expression
of N-cadherin to ensure proper pericyte
coverage and cerebrovascular integrity (Li
et al., 2011). Besides symptomatic interven-
tional procedures, initial attempts are beingmade to explore molecular targeted therapy (pre)clinically,
including the use of the anti-VEGF antibody bevacizumab to
inhibit the raised VEGF levels that cause overgrowth of immature
vessel anomalies, and thalidomide to restore vessel maturation
by upregulating PDGF-B (Lebrin et al., 2010).
Cerebrovascular cavernous malformations (CCMs) are char-
acterized by collections of dilated, leaky capillary caverns vulner-
able to rupture and bleeding. Apart from other theories, one
model postulates that CCMs arise by venous dysplasia, leading
to venous hypertension and secondary hypoxia, which then
upregulates angiogenic factors and induces EC growth. Since
these lesions consist largely of ECs alone without support of
pericytes or other neural cells, deregulated EC-autonomous
mechanisms were suspected disease candidates. Indeed, in in-
herited cases, haploinsufficient mutations of three CCM genes,
encoding KRIT1 (CCM1), malcaverin (CCM2), or PDCD10
(CCM3), are linkedwith this condition (Leblanc et al., 2009b; Lon-
don et al., 2009). EC-selective loss-of-function studies confirmed
the endothelial cell-autonomous role of the CCM genes, while
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disease models that reliably reflect the human condition (Cun-
ningham et al., 2011). A second hit theory, in which the residual
allele is lost via somatic mutation in single ECs in subjects with
a monoallelic germline mutation, might explain their focal nature,
though genetic mutations in other pathway members or environ-
mental pro-angiogenic conditions cannot be excluded as second
hit either.
Functional studies have only begun to unravel the complex
molecular pathology. CCMs are intracellular proteins that act in
a trimolecular complex as scaffolds linking molecules on the
cell surface (integrins, VE-cadherin, orphan receptor HEG1)
to downstream intracellular signaling cascades in order to
regulate cytoskeletal actin dynamics, vessel branching, lumen
generation, barrier formation, endothelial lining repair, and other
morphogenetic processes (Faurobert and Albiges-Rizo, 2010).
The uncontrolled angiogenic signaling in CCM may be also
related to inhibition of Dll4/Notch signaling (Wu¨stehube et al.,
2010). Like Dll4 blockade, loss of CCM1 results in hyperprolifer-
ative vascular lesions by activating b-catenin driven gene tran-
scription (Glading and Ginsberg, 2010; Yan et al., 2010).
However, the precise pathophysiology of CCM remains incom-
pletely understood, as CCM3 stabilizes VEGFR2 signaling,
a molecular pathway promoting tip cell formation (He et al.,
2010). Based on insights implicating RhoA in the CCM pathway,
inhibitors of Ras signaling are being evaluated as possible ther-
apeutics (Borikova et al., 2010).
Besides monogenic cases, various other diseases character-
ized by vascular abnormalities occur sporadically and are likely
polygenic in nature. Elucidating the genetic basis of cerebrovas-
cular malformations promises not only to understand better how
CNS vessels form but also to develop much needed molecular
targeted therapies for these conditions. An example is the
successful treatment of ocular neovascularizationwith ablocking
anti-VEGF antibody in patients suffering the wet form of age
related macular degeneration, a prime cause of blindness in
the elderly (Campa and Harding, 2011).
Insufficient Neurotrophic Signaling by Endothelial
or Angiogenic Factors
Angioneurins not only direct neurovascular development, but
are also indispensable signal molecules governing neuroprotec-
tion and -regeneration in adulthood. Genetic evidence that insuf-
ficient neurotrophic signaling by angiogenic factors can promote
neurodegeneration stems from the ALS field, where reduced
VEGF levels in VEGFv/v mice and in humans are associated
with motoneuron degeneration (Ruiz de Almodovar et al.,
2009). Besides a role for hypoperfusion, deficient neuroprotec-
tive signaling is relevant since neuronal overexpression of
VEGFR2 delays disease progression in ALS mouse models.
Two other examples of insufficient neuroprotective signaling
include Kennedy’s disease where the mutated expanded
androgen receptor interferes with VEGF transcription and,
second, ALS caused by mutations in angiogenin, both resulting
in impaired motoneuron survival (Ruiz de Almodovar et al.,
2009; Sebastia` et al., 2009). Disturbances in axonal outgrowth
and synaptic plasticity represent additional mechanisms.
Indeed, in ALS patients and animal models, there is evidence
for an imbalance of repulsive over attractive axon guidancecues (Schmidt et al., 2009), while motoneurons from VEGFv/v
mice express lower levels of genes involved in axonogenesis
(Brockington et al., 2010). Additionally, inappropriate proteoso-
mal degradation of the axon guidance molecule EphB2 contrib-
utes to AD pathogenesis by perturbing NMDA-receptor depen-
dent long-term potentiation (Cisse´ et al., 2011).
Is the Neurovascular Stem Cell Niche Involved?
ECs not only build channels to conduct oxygen and nutrients, but
also provide neurotrophic signals and create a niche facilitating
neuronal maintenance and repair, independently of perfusion.
Specialized niches in the subependymal zone (SEZ) of the lateral
ventricles and in the subgranular zone (SGZ) of the hippocampal
dentate gyrus harbor a population of adult NSCs that generate
new neurons throughout life (Butler et al., 2010; Goldberg and
Hirschi, 2009) (Figure 4B). In both niches, cycling neural progen-
itors are found in close proximity to vessels in the neurovascular
stem cell niche (Shen et al., 2008; Tavazoie et al., 2008);
however, the nature of the SEZ and SGZ niches is different.
In the adult SEZ, the niche is derived from the periventricular
vascular plexus and is already present in development. ECs
in this niche are quiescent and the BBB allows passage of
low-molecular-weight circulating substances (Tavazoie et al.,
2008). Slowly dividing NSCs with long-term self-renewal poten-
tial are not located in close vicinity of periventricular vessels, but
contact them via endfeet of their long basal processes (Becker-
vordersandforth et al., 2010; Shen et al., 2008). These NSCs
express VEGFR3, required for NSC maintenance and olfactory
bulb neurogenesis (Calvo et al., 2011). Once activated to initiate
division, NSCs and the continuously proliferating transit-ampli-
fying progenitors (TAPs) become attracted to periventricular
vessels via SDF1-CXCR4 signaling (Kokovay et al., 2010; Tava-
zoie et al., 2008). The perivascular ECM in the SEZ niche func-
tions as a deposit of growth factors to support neural precursor
proliferation. Thus, signals derived from SEZ vessels foster
proliferation of neural precursors, while long-term self-renewing
stem cells are located in the more hypoxic niche to maintain
quiescence (Mohyeldin et al., 2010).
The development of the SGZ niche occurs primarily postna-
tally. SGZ vessels have an intact BBB and restrict access of
systemic factors to NSCs. Proliferation of NSCs and neural
progenitors is tightly coupled to SGZ angiogenesis, and prolifer-
ating ECs and neural precursors colocalize in the niche (Van der
Borght et al., 2009). Stimuli like exercise increase hippocampal
neurogenesis and angiogenesis by upregulating VEGF in this
niche. However, besides direct neurogenic and angiogenic
effects of VEGF, expansion of the vascular niche alone can
also contribute, since persistent vascular expansion in the SGZ
induced by transient overexpression of VEGF increases neuro-
genesis even after cessation of VEGF expression (Licht et al.,
2011).
Vessels provide a substrate for guidance of migrating neuro-
blasts in adult neurogenesis and facilitate long-range migration
of neuroblasts out of the SEZ toward the olfactory bulb (OB)
along the rostral migratory stream (RMS) (Figure 4C) (Sagha-
telyan, 2009). RMS vessels are aligned parallel to the route of
neuroblast migration, and nearly all migrating cells are attached
to vessels (Snapyan et al., 2009). ECs attract the neuroblasts by
releasing BDNF; once attracted, neuroblasts release GABA,Neuron 71, August 11, 2011 ª2011 Elsevier Inc. 417
Table 1. Monogenetic Cerebrovascular Disorders
Disease Gene Human Features
Disease Mouse
Model
Molecular
Pathogenesis Reference
Small Vessel Disease
CADASIL Notch3
(signaling
receptor)
migraine, stroke,
white matter
lesions, dementia;
cerebrovascular
dysregulation
mutant Notch3:
vascular GOM
deposits; Notch3
ectodomain
aggregates, white
matter lesions
SMC degeneration;
capillary pruning;
cerebrovascular
dysregulation and
hypoperfusion
Joutel, 2011
CARASIL Htra1
(protease)
ischemic stroke,
white matter lesions,
dementia
no in vivo model
available
mutant HTRA1
fails to repress
TGFb signaling
Shiga et al., 2011
RVLC Trex1
exonuclease
stroke, cognitive
decline, white matter
lesions, visual loss
no in vivo model
available
altered TREX1
subcellular
localization
Richards et al., 2007
COL4A1-associated
syndromes
Col4A1
(collagen IV)
perinatal bleeding;
porencephaly,
adult-onset small
vessel disease; stroke,
bleeding, arteriolar
tortuosity, and HANAC
syndrome
Col4A1 missense
mutation: perinatal
cerebral hemorrhages,
endothelial detachment
from SMC; disturbed
vasoregulation
reduced basement
membrane integrity
and disruption of
vessel ECM; abnormal
vasoregulation via
disturbed NO/cGMP
Lanfranconi and
Markus, 2010
Vascular Wall Integrity Defects
Marfan’s
syndrome
Fbn1
(fibronectin),
TGFR2
(TGF- receptor)
aortic root dilatation,
aortic dissection
Fbn1/ mice and mice
with hypomorphic Fbn
mutation: dissecting
aortic aneurysm
reduced microfibrillar
synthesis, excessive
TGFb signaling
Mizuguchi et al., 2004;
Pereira et al., 1999
Ehlers Danlos
type IV
Col3A1
(collagen III)
arterial dissection,
arterial aneurysm
Col3A1+/D mutant
mice: aortic dissection
and rupture
abnormal synthesis
of collagen III
Smith et al., 2011
Pseudo-xanthoma
elasticum
Abcc6
(ABC transporter
protein 6)
arterial dissection,
hypertension,
gastrointestinal
bleeding
Abcc6/ mice:
calcification of
arteries
dystrophic
calcification of elastic
fibers in arteries
Li and Uitto, 2010
Hereditary
CAA: Ab forms*
APP (amyloid
precursor
protein)
vascular amyloid
deposition resulting in
cerebral hemorrhage,
cognitive decline
APP mutations:
amyloid deposition;
microaneurysms,
bleeding, and
cognitive decline
deposition of Ab42 in
vessel wall, disturbing
vasoregulation and
vessel wall integrity
Kumar-Singh, 2009
Polycystic kidney
disease
Pkd1/2
(polycystin)
intracranial aneurysm,
dolichoectasias, aortic
dilatation, and
dissection
Pkd1 hypomorphic
mice: dissecting
aortic aneurysms
impaired contact
between SMC and
elastin; vessel wall
desintegration
Hassane et al., 2007
Loeys-Dietz
syndrome
Tgfbr1, Tgfbr2
(TGF-b
receptor)
aortic and arterial
aneurysm, dissection,
tortuosity, and
elongation of carotid
arteries
no in vivo model
available
excessive TGFb
signaling results in
disorganized elastic
lamina
Loeys et al., 2005
Vascular Malformations
HHT Eng (endoglin);
Acvrl1 (Alk1),
Smad4
AVM, telangiectasia,
resulting in cerebral
hemorrhages,
headache, seizures
Eng+/ mice: nosebleed;
telangiectasia, bleeding;
Acvrl1+/ mice: vessel
lesions in multiple
organs; endothelial
Smad4 null: cerebral
hemorrhage, AVMs
reduction in TGFb
signaling; loss of
EC-SMC adhesion
through
downregulation
of N-cadherin
Shovlin, 2010
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Table 1. Continued
Disease Gene Human Features
Disease Mouse
Model
Molecular
Pathogenesis Reference
CCM Ccm1, Ccm2,
Ccm3
headache, seizures,
hemorrhages
Ccm1/, Ccm2/,
Ccm3/ mice:
defective angiogenesis;
Ccm1+/ Trp53/
mice: cerebral
bleeding in adult
abnormal signal
transduction of
integrins, junctional
molecules and other
membrane receptors,
leading to perturbed
EC cytoskeletal
dynamics, shape
and growth
Leblanc
et al., 2009a
Others
Familial Moyamoya
disease
polygenic progressive stenosis
of carotid arteries
causing excessive
growth of collaterals;
stroke, bleeding,
seizures
no in vivo model
available
stenosis (due to SMC
hyperplasia) induces
(via HIF1) growth
of dysfunctional,
aneurysmatic
collateral vessels
Scott and
Smith, 2009
Fabry’s disease Gla
(galactosidase)
ischemic stroke,
angiokeratomas
GLA/ mice:
deposition
of glycosphingolipids
in organs and
vasculature; without
symptoms
deposition of
glycosphingolipids
in vessels; brain
hyperperfusion but
impaired vasoreactivity
Moore et al., 2007
Neurofibromatosis
type 1
Nf1
(neuro-fibromin)
arterial occlusive
disease (hypertension,
stroke), aneurysms,
AVF; learning deficits
NF1+/ mice: thickening
of arterial walls upon
mechanical injury;
learning deficits
increased SMC
hyperplasia and
neointima formation
Lasater et al., 2008
MELAS Mitochondrial
DNA mutations
ischemic episodes,
reduced cerebral
blood flow
no in vivo model
available
mitochondrial
abnormalities in EC
Zhang et al., 2010
*Non-Ab forms will not be discussed here. GOM: granular osmiophilic material; CARASIL: cerebral autosomal recessive arteriopathy with subcortical
infarcts and leukoencephalopathy; RVLC: retinal vasculopathy with cerebral leukodystrophy; Col4A1: collagen type 4, A1 isoform; HANAC: hereditary
angiopathy with nephropathy, aneurysms, and muscle cramps; porencephaly: cerebral cyst, remnant of destructive lesion; HHT: hereditary hemor-
rhagic telangiectasia; CCM: cerebrovascular cavernous malformation; MELAS: mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke;
AVM: arteriovenous malformation; AVF: arteriovenous fistulae.
Neuron
Reviewwhich triggers nearby astrocytes to take up BDNF, thereby
ensuring navigation along RMS vessels. VEGF also regulates
neuroblast migration along the RMS (Wittko et al., 2009).
In acute brain insults, hypoxia triggers a neurovascular
response that results in increased angiogenic and neurogenic
activity at the border of the lesion. This adaptive response can
last for months and is associated with functional recovery (Jin
et al., 2010). This regenerative response relies on reciprocal
neurovascular interactions. Indeed, after stroke, neuroblasts
deviate from the RMS and are attracted to the growing vascula-
ture by SDF-1a and Ang1 in the peri-infarct cortex (penumbra),
where they start neurogenesis (Saghatelyan, 2009). Vessels
also serve as substrate for migrating neural precursors into
infarcted regions (Kojima et al., 2010). Conversely, neural pro-
genitors from the ischemic SVZ promote angiogenesis (Teng
et al., 2008). Disruption of the interaction between NSCs and
vessels in the niche by cranial irradiation prevents neurogenesis
(Goldberg and Hirschi, 2009). Through plastic differentiation,
pericytes can also contribute to glial scar formation after spinal
cord injury (Go¨ritz et al., 2011).NSCs can give rise to glioblastoma (GBM) (Wang et al., 2009)
and GBM stem cells are also located in vascular niches, which
they create by secreting VEGF (Gilbertson and Rich, 2007).
However, GBM stem cells can also give rise to tumor-derived
endothelium by differentiation to ECs (Ricci-Vitiani et al.,
2010; Wang et al., 2010a). In the niche, vessels contribute to
GBM stem cell maintenance by secretion of eNOS to activate
Notch signaling, but ECs also secrete unidentified factors to
maintain and expand GBM stem cells (Galan-Moya et al.,
2011; Gilbertson and Rich, 2007). Ablation of the vasculature
decreases stem cell numbers in GBM and sensitizes the nor-
mally protected stem cells to irradiation damage (Hovinga
et al., 2010).
Therapeutic Perspectives for Neurovascular Medicine
From the above, it is evident that angiogenesis offers a range of
therapeutic opportunities. Given the scope of the review, we will
outline, as prototypic example, one emerging neurovascular
therapeutic approach, which has recently progressed to clinical
testing.Neuron 71, August 11, 2011 ª2011 Elsevier Inc. 419
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generation is VEGF. Based on the aforementioned insights,
VEGF therapy was explored. Both VEGF gene transfer in moto-
neurons as well as intracerebroventricular (ICV) VEGF protein
delivery prolonged the survival of ALS rodent models (Ruiz de
Almodovar et al., 2009). The therapeutic effect of VEGF in ALS
relies on a neuroprotective effect, in addition to a possible effect
on microvascular maintenance or perfusion (Ruiz de Almodovar
et al., 2009). The benefit of ICV delivery of VEGF protein for ALS
patients is currently being clinically evaluated in phase I/II trials.
Deficiency of another VEGF family member, e.g., VEGF-B, does
not cause ALS by itself, but aggravates motor neuron degenera-
tion in ALS mouse models (Poesen et al., 2008). ICV delivery of
recombinant VEGF-B also reduces motor neuron death and
prolongs survival in an ALS model, without causing any observ-
able adverse effects on vessel growth or permeability.
Conclusion and Outstanding Questions
The ‘‘neurocentric’’ viewpoint about neurodegeneration and
several other neurological disorders has prevailed for a long
time. However, in the last two decades, the brain vasculature
has increasingly entered the center stage as a key player that
actively influences and directs brain development, homeostasis,
and disease. Despite tremendous progress in understanding the
functional properties of brain vessels in recent years, numerous
questions remain unanswered. We will highlight here only a few
examples. For instance, emerging evidence suggests that vessel
growth in the brain relies in part on specific, perhaps even unique
proangiogenic signals. Identifying their molecular nature offers
great promise to understand neurovascular disorders and to
develop novel neurovascular medicine. Second, the role of peri-
cytes has turned out to bemore important than previously recog-
nized. Do pericyte abnormalities causally contribute to neurode-
generation and other types of neurological disorders, and can
they be therapeutically targeted? Finally, the brain vasculature
is now considered to be a major contributor of the neurogenic
stem cell niche. Can this process be exploited for brain repair?
Finding an answer to these and other questions promises to be
a scientifically exciting journey with great translational potential.
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